Laughing Water Capital, an investment management company, released its fourth-quarter 2024 investor letter. A copy of the ...

Lifecore’s board of directors has approved that holders of record of Lifecore’s Common Stock and Convertible Preferred Stock as of the close of business on February 18, 2025 (the “Record Date”), will ...

CHASKA, Minn., Jan. 17, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing ...

Lifecore Biomedical, Inc. announced plans to hold a special stockholders meeting on April 10, 2025, to seek approval for a proposal related to its Series A Convertible Preferred Stock. The ...

In a challenging turn of events for Ocean Biomedical, the company's stock has tumbled to a 52-week low, reaching a price ...

On January 16, 2025, Neuraly Inc. (Neuraly), a wholly owned subsidiary of D&D Pharmatech Inc., and Enigma Biomedical USA, Inc. (Enigma) announced the signing of a research license and ...

GE HealthCare announces the launch of a Care Innovation Hub, a joint research collaboration with the University of California ...

Earlier this month, Moderna announced business updates and progress across its pipeline. Moderna says it enters 2025 with a ...

HOUSTON, TEXAS / ACCESS Newswire / January 23, 2025 / US Med-Equip (USME) the nation's highest-rated provider of medical equipment rentals, sales, biomedical support and asset management service, team ...

WayPoint Biomedical Holdings, Inc., through its wholly owned subsidiary, WayPoint Biomedical, Inc., engages in the development and marketing of diagnostic tests and devices for screening and ...

Moderna, Inc. (NASDAQ:MRNA) today announced ongoing support from the U.S. Department of Health and Human Services (HHS) to accelerate the development of mRNA-based pandemic influenza vaccines. The ...